Table 5.
Baseline characteristics according to antibody concentration trajectory.
| Constant mild antibody concentration n = 311 | Constant moderate antibody concentration n = 128 | Higher antibody concentration n = 35 | |
|---|---|---|---|
| Sex | |||
| Women | 244 (78.5%) | 100 (78.1%) | 21 (60.0%) |
| Men | 67 (21.5%) | 28 (21.9%) | 14 (40.0%) |
| Age group (y) | |||
| 18–35 | 79 (25.4%) | 18 (14.1%) | 5 (14.3%) |
| 36–55 | 163 (52.4%) | 55 (43.0%) | 13 (37.1%) |
| 56–96 | 69 (22.2%) | 55 (43.0%) | 17 (48.6%) |
| BMI categories | |||
| Underweight/Normal (BMI < 24.99 kg/m2) | 161 (52.1%) | 55 (43.3%) | 14 (40.0%) |
| Overweight/Obese (BMI ≥25 kg/m2) | 148 (47.9%) | 72 (56.7%) | 21 (60.0%) |
| Multimorbidity | |||
| 0–1 | 251 (91.3%) | 97 (84.4%) | 29 (93.8%) |
| ≥2 | 24 (8.7%) | 18 (15.7%) | 3 (9.4%) |
| Type of disease | |||
| Asymptomatic | 60 (19.29%) | 19 (14.84%) | 6 (17.1%) |
| Symptomatic | 251 (80.7%) | 109 (85.2%) | 29 (82.9%) |
| Severity | |||
| Asymptomatic, mild to moderate | 293 (95.2%) | 112 (88.2%) | 28 (82.4%) |
| Severe | 16 (45.2%) | 12 (9.5%) | 4 (11.8%) |
| Critical | 1 (0.3%) | 3 (2.4%) | 2 (5.9%) |
| Antibodies (mean ± sd) | 35.0 ± 23.8 | 104.9 ± 38.9 | 205.4 ± 73.9 |